Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03GWY
|
||||
| Former ID |
DNC000431
|
||||
| Drug Name |
Ciglitazone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H23NO3S
|
||||
| InChI |
InChI=1S/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21)
|
||||
| InChIKey |
YZFWTZACSRHJQD-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 74772-77-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
6897912, 7978942, 8151777, 11120025, 11120513, 11121001, 11121640, 11122120, 11147108, 11362709, 11365271, 11367833, 11370689, 11370690, 11373434, 11375995, 12012730, 14899936, 17397629, 22391558, 24892661, 26681499, 26752160, 26752161, 26752162, 26757865, 26758470, 29221905, 46488049, 47216537, 47810501, 48110200, 48334208, 50052262, 50104808, 50620095, 53788148, 56312056, 56314037, 57321433, 85788733, 91611856, 92309991, 95612759, 99300903, 99302423, 103165086, 103853966, 104046501, 104301499
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [536772] | |
| PANTHER Pathway | CCKR signaling map ST | ||||
| WikiPathways | Wnt Signaling Pathway Netpath | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| Differentiation of white and brown adipocyte | |||||
| Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
| Transcriptional Regulation of White Adipocyte Differentiation | |||||
| Adipogenesis | |||||
| SREBP signalling | |||||
| Nuclear Receptors | |||||
| References | |||||
| Ref 539772 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2711). | ||||
| Ref 545679 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004145) | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.